This website uses necessary cookies for its operation and optional cookies to improve the experience, personalize content, and analyze usage. For more information, please refer to our Privacy Policy and Cookie Policy.
10/3/2026

Medifarma Humanova and Minera Lincuna Deliver Advanced Prosthetic Technology to Personnel of the peruvian Army

Donation of Advanced Prosthetic Technology to Personnel of the peruvian Army.
foto-noticia-oficiales-humanova
h transparente

Yesterday, a meaningful ceremony was held for the delivery of state of the art prosthetics to personnel of the peruvian Army who, in the line of duty, faced significant challenges and sacrifices and now live with disabilities after losing their lower limbs.

This initiative has been underway for the past two years, following the first coordination efforts led by the Reserve Personnel of the peruvian Army through the Army Health Command (COSALE), in collaboration with Medifarma part of the global holding humanova and the mining company Lincuna, both companies belonging to the Picasso Candamo Group.

From the Pentagonito facilities, both companies—represented by senior executives, as well as by personnel from COSALE and members of the Peruvian Army Reserve—reaffirmed their commitment to ensuring that the experience gained from this first initiative will facilitate the process for future donations, in benefit of and as a gesture of appreciation to the military personnel who served the country in the fulfillment of their duty.

The prosthetics, developed using cutting-edge technology, were manufactured by the peruvian company HORUS. These devices represent a technical solution that will enable the beneficiaries to regain mobility and autonomy, while significantly improving their quality of life.

Medifarma and Lincuna expressed their gratitude for the opportunity to contribute in a direct and meaningful way to the well-being of those who have given so much in service to Peru, and they hope that more private institutions will join this inspiring effort.

donación-humanova-medifarma
medifarma-humanova-2026